Hoth Therapeutics, Inc.
USD1.34
-0.12 (-8.21%)
CEO
Robb Knie
IPO Date
2019-02-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.28
Prev. Close
$1.46
Day Low
$1.17
Day High
$1.50
52W Low
$0.49
52W High
$2.20
Market Cap
$0.02B
Volume
7.28M
| 310,744 |
| $1.21 |
| 21 May 2025 | Camarra Christopher Michael | director: | Disposed | 0 | $0.00 |
| 15 Jan 2025 | Springer Graig | director | A-Award | Acquired | 70,000 | $1.55 |
| 15 Jan 2025 | Knie Robb | director, officer: CEO and President | A-Award | Acquired | 93,000 | $1.55 |
| 15 Jan 2025 | Knie Robb | director, officer: CEO and President | A-Award | Acquired | 7,000 | $1.55 |
| 21 Aug 2024 | Springer Graig | director | A-Award | Acquired | 48,000 | $0.75 |
| 21 Aug 2024 | Springer Graig | director | A-Award | Acquired | 25,000 | $0.75 |
| 21 Aug 2024 | Knie Robb | director, officer: CEO and President | A-Award | Acquired | 325,000 | $0.75 |
| 21 Aug 2024 | Linsley Wayne | director | A-Award | Acquired | 25,000 | $0.75 |